• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Letter by Long and Jiang Regarding Article, "Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients With Familial Hypercholesterolemia: The ARCHITECT Study".

作者信息

Long Xingqing, Jiang Mingyang

机构信息

First Clinical School of Medicine, Guang Xi Medical University, Nanning, China (X.L.).

Department of Bone and Joint Surgery, First Affiliated Hospital of Guangxi Medical University, Nanning, China (M.J.).

出版信息

Circulation. 2023 Sep 26;148(13):1058. doi: 10.1161/CIRCULATIONAHA.123.065391. Epub 2023 Sep 25.

DOI:10.1161/CIRCULATIONAHA.123.065391
PMID:37747950
Abstract
摘要

相似文献

1
Letter by Long and Jiang Regarding Article, "Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients With Familial Hypercholesterolemia: The ARCHITECT Study".龙和江就“阿利西尤单抗与家族性高胆固醇血症无症状患者的冠状动脉粥样硬化：ARCHITECT研究”一文所写的信。
Circulation. 2023 Sep 26;148(13):1058. doi: 10.1161/CIRCULATIONAHA.123.065391. Epub 2023 Sep 25.
2
Response by Pérez de Isla et al to Letter Regarding Article, "Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients With Familial Hypercholesterolemia: The ARCHITECT Study".佩雷斯·德·伊斯拉等人对关于“阿利西尤单抗与家族性高胆固醇血症无症状患者的冠状动脉粥样硬化：ARCHITECT研究”一文的信件的回复
Circulation. 2023 Sep 26;148(13):1059-1060. doi: 10.1161/CIRCULATIONAHA.123.066276. Epub 2023 Sep 25.
3
Letter by Aldana-Bitar et al Regarding Article, "Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients With Familial Hypercholesterolemia: The ARCHITECT Study".阿尔达纳 - 比塔尔等人就“阿利西尤单抗与家族性高胆固醇血症无症状患者的冠状动脉粥样硬化：ARCHITECT研究”一文所写的信。
Circulation. 2023 Sep 26;148(13):1057. doi: 10.1161/CIRCULATIONAHA.123.065198. Epub 2023 Sep 25.
4
Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients with Familial Hypercholesterolemia: The ARCHITECT Study.依洛尤单抗与家族性高胆固醇血症无症状患者的冠状动脉粥样硬化：ARCHITECT 研究。
Circulation. 2023 May 9;147(19):1436-1443. doi: 10.1161/CIRCULATIONAHA.122.062557. Epub 2023 Apr 3.
5
The treatment of heterozygous familial hypercholesterolemia - a local perspective.杂合子家族性高胆固醇血症的治疗——本地视角
Endokrynol Pol. 2021;72(3):189-190. doi: 10.5603/EP.a2021.0055.
6
Coronary Artery Calcification and Risk Stratification in Familial Hypercholesterolemia: Moving Forward But Not There Yet.家族性高胆固醇血症中的冠状动脉钙化与风险分层：虽有进展但仍未达标
JACC Cardiovasc Imaging. 2021 Dec;14(12):2425-2428. doi: 10.1016/j.jcmg.2021.06.013. Epub 2021 Jul 14.
7
Achilles tendon xanthomas are associated with the presence and burden of subclinical coronary atherosclerosis in heterozygous familial hypercholesterolemia: A pilot study.杂合子家族性高胆固醇血症患者的跟腱黄色瘤与亚临床冠状动脉粥样硬化的存在和负担相关：一项初步研究。
Atherosclerosis. 2017 Aug;263:393-397. doi: 10.1016/j.atherosclerosis.2017.04.025. Epub 2017 Apr 30.
8
Regional Variations in Alirocumab Dosing Patterns in Patients with Heterozygous Familial Hypercholesterolemia During an Open-Label Extension Study.在一项开放性延伸研究中，杂合子家族性高胆固醇血症患者接受依洛尤单抗治疗的剂量模式存在区域性差异。
Cardiovasc Drugs Ther. 2020 Aug;34(4):515-523. doi: 10.1007/s10557-020-06984-0.
9
Polyvascular subclinical atherosclerosis in familial hypercholesterolemia: The role of cholesterol burden and gender.家族性高胆固醇血症患者的多血管亚临床动脉粥样硬化：胆固醇负担和性别的作用。
Nutr Metab Cardiovasc Dis. 2019 Oct;29(10):1068-1076. doi: 10.1016/j.numecd.2019.06.015. Epub 2019 Jul 3.
10
Subclinical coronary atherosclerosis and cardiovascular risk stratification in heterozygous familial hypercholesterolemia patients undergoing statin treatment.杂合子家族性高胆固醇血症患者他汀类药物治疗后的亚临床冠状动脉粥样硬化与心血管风险分层。
Curr Opin Lipidol. 2019 Apr;30(2):82-87. doi: 10.1097/MOL.0000000000000573.